Cargando…

Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer: the HIL trial

BACKGROUND: Radiotherapy, preferably combined with chemotherapy, is the treatment standard for locally advanced, unresectable non-small cell lung cancer (NSCLC). The tumor response to different therapy protocols is variable, with hypoxia known to be a major factor that negatively influences treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Askoxylakis, Vasileios, Dinkel, Julien, Eichinger, Monika, Stieltjes, Bram, Sommer, Gregor, Strauss, Ludwig G, Dimitrakopoulou-Strauss, Antonia, Kopp-Schneider, Annette, Haberkorn, Uwe, Huber, Peter E, Bischof, Marc, Debus, Jürgen, Thieke, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503648/ https://www.ncbi.nlm.nih.gov/pubmed/22974533 http://dx.doi.org/10.1186/1748-717X-7-157

Ejemplares similares

Quantitative Dynamic (18)F-FDG PET/CT in Survival Prediction of Metastatic Melanoma under PD-1 Inhibitors
por: Sachpekidis, Christos, et al.
Publicado: (2021)

Peptide-Based Targeting of the Platelet-Derived Growth Factor Receptor Beta
por: Askoxylakis, Vasileios, et al.
Publicado: (2012)

Interim [(18)F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma
por: Sachpekidis, Christos, et al.
Publicado: (2020)

Long-term survival of cancer patients compared to heart failure and stroke: A systematic review
por: Askoxylakis, Vasileios, et al.
Publicado: (2010)

Comparison between (68)Ga-bombesin ((68)Ga-BZH3) and the cRGD tetramer (68)Ga-RGD(4 )studies in an experimental nude rat model with a neuroendocrine pancreatic tumor cell line
por: Cheng, Caixia, et al.
Publicado: (2011)

Optimization of a Novel Peptide Ligand Targeting Human Carbonic Anhydrase IX
por: Rana, Shoaib, et al.
Publicado: (2012)

Investigation of tumor hypoxia using a two-enzyme system for in vitro generation of oxygen deficiency
por: Askoxylakis, Vasileios, et al.
Publicado: (2011)

Binding of the Phage Display Derived Peptide CaIX-P1 on Human Colorectal Carcinoma Cells Correlates with the Expression of Carbonic Anhydrase IX
por: Askoxylakis, Vasileios, et al.
Publicado: (2012)

A New Peptide Ligand for Targeting Human Carbonic Anhydrase IX, Identified through the Phage Display Technology
por: Askoxylakis, Vasileios, et al.
Publicado: (2010)

Challenges in Optimizing a Prostate Carcinoma Binding Peptide, Identified through the Phage Display Technology
por: Askoxylakis, Vasileios, et al.
Publicado: (2011)

Assessment of early metabolic progression in melanoma patients under immunotherapy: an (18)F-FDG PET/CT study
por: Sachpekidis, Christos, et al.
Publicado: (2021)

Quantitative approaches of dynamic FDG-PET and PET/CT studies (dPET/CT) for the evaluation of oncological patients
por: Dimitrakopoulou-Strauss, Antonia, et al.
Publicado: (2012)

The prognostic value of [(18)F]FDG PET/CT based response monitoring in metastatic melanoma patients undergoing immunotherapy: comparison of different metabolic criteria
por: Sachpekidis, Christos, et al.
Publicado: (2023)

Pharmacokinetic studies of [(68) Ga]Ga-PSMA-11 in patients with biochemical recurrence of prostate cancer: detection, differences in temporal distribution and kinetic modelling by tissue type
por: Strauss, Dimitrios S., et al.
Publicado: (2021)

Intensity modulated radiotherapy (IMRT) in benign giant cell tumors -- a single institution case series and a short review of the literature
por: Roeder, Falk, et al.
Publicado: (2010)

Correlation of Dynamic PET and Gene Array Data in Patients with Gastrointestinal Stromal Tumors
por: Strauss, Ludwig G., et al.
Publicado: (2012)

Application of the long axial field-of-view PET/CT with low-dose [(18)F]FDG in melanoma
por: Sachpekidis, Christos, et al.
Publicado: (2022)

Immuno-Imaging (PET/SPECT)–Quo Vadis?
por: Kramer, Carsten S., et al.
Publicado: (2022)

Can (18)F-NaF PET/CT before Autologous Stem Cell Transplantation Predict Survival in Multiple Myeloma?
por: Sachpekidis, Christos, et al.
Publicado: (2020)

Can physiologic colonic [(18)F]FDG uptake in PET/CT imaging predict response to immunotherapy in metastatic melanoma?
por: Sachpekidis, Christos, et al.
Publicado: (2023)

Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer
por: Roeder, Falk, et al.
Publicado: (2011)

The stability of osseous metastases of the spine in lung cancer – a retrospective analysis of 338 cases
por: Rief, Harald, et al.
Publicado: (2013)

Level of TNF-related apoptosis-inducing-ligand and CXCL8 correlated with 2-[18F]Fluoro-2-deoxy-D-glucose uptake in anti-VEGF treated colon cancers
por: Celik, Betül, et al.
Publicado: (2013)

Positron Emission Tomography as a Surrogate Marker for Evaluation of Treatment Response in Patients with Desmoid Tumors under Therapy with Imatinib
por: Kasper, Bernd, et al.
Publicado: (2013)

Diffusion-weighted imaging-based probabilistic segmentation of high- and low-proliferative areas in high-grade gliomas
por: Simon, Dirk, et al.
Publicado: (2012)

A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma
por: Schmitt, Thomas, et al.
Publicado: (2011)

Multimodality treatment in unresectable cholangiocarcinoma
por: Aghili, Mahdi, et al.
Publicado: (2020)

Detection and characterization of the S. typhimurium HilA protein
por: Rodriguez, Christine R, et al.
Publicado: (2002)

Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: a single center retrospective analysis
por: Askoxylakis, Vasileios, et al.
Publicado: (2014)

Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Basic and clinical immunology – 3031. The correlation between serum protemics patterns of sTRAIL and CXCL8 with FDG-PET/CT findings in bevacizumab treated colon cancers
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma
por: Sachpekidis, Christos, et al.
Publicado: (2019)

Quantitative, Dynamic (18)F-FDG PET/CT in Monitoring of Smoldering Myeloma: A Case Report
por: Sachpekidis, Christos, et al.
Publicado: (2021)

Kinetic modeling and parametric imaging with dynamic PET for oncological applications: general considerations, current clinical applications, and future perspectives
por: Dimitrakopoulou-Strauss, Antonia, et al.
Publicado: (2020)

Long axial field of view (LAFOV) PET-CT: implementation in static and dynamic oncological studies
por: Dimitrakopoulou-Strauss, Antonia, et al.
Publicado: (2023)

Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis
por: Askoxylakis, Vasileios, et al.
Publicado: (2016)

Comparison of functional imaging in multiple myeloma patients: Indication for hybrid-imaging with PET/MRI?
por: Mosebach, J, et al.
Publicado: (2015)

Human NK cell development in hIL-7 and hIL-15 knockin NOD/SCID/IL2rgKO mice
por: Matsuda, Masashi, et al.
Publicado: (2019)

The prognostic significance of [(18)F]FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs)
por: Sachpekidis, Christos, et al.
Publicado: (2021)

HilE represses the activity of the Salmonella virulence regulator HilD via a mechanism distinct from that of intestinal long-chain fatty acids
por: Joiner, Joe D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c937jfkg6d00l960pcg8qj29b6